2018•Journal of HypertensionRequires access

SELF-MONITORING IS NOT JUST FOR A STUDY, SELF-MONITORING IS FOR LIFE

Claire Schwartz, Constantinos Koshiaris, Emma P Bray, Samantha H. Greenfield, Sayeed M Haque, Richard F. Hobbs, Paul S Little, Jonathan Mant, Bryan Williams, Richard J. McManus

Open publisher page 0 citations

Abstract

Objective: Self-management in the TASMIN-SR trial successfully reduced and controlled blood pressure (BP) compared to clinic monitoring over 12 months. This study aimed to assess how self-management affected patient preference towards future management of BP. Design and Methods: Patients with hypertension, above target clinic BP and one-or-more of stroke, diabetes, coronary heart disease or chronic kidney disease, were randomised to a self-management intervention (self-monitoring with self-titration) or usual clinic BP management. At baseline and 12 months patients were asked to rank methods of BP measurement and at 12 month follow-up were asked: “Are you planning to continue/start to self-monitor your BP after the study? Why?” Responses were coded thematically by trial arm and according to whether patients planned to continue self-monitoring. Themes were identified from the resulting codes. Scientific Data: Quantitative data regarding ranked preference for self-monitoring plus qualitative data from free text responses. Results and Conclusions: At baseline, self-monitoring was ranked as the preferred method of BP measurement by both intervention and usual care groups, but only intervention patients continued to rank self-monitoring as their preferred choice at 12 months, usual care patients preferring health professional measurement. Self-management patients were three times more likely to want to continue self-monitoring following the trial (OR 3.9 (95% CI 2.62 – 5.87; p < 0.0001). Overarching themes summarising reasons expressed by patients who wanted to continue self-monitoring included: “Positive effects of self-monitoring”; “Concern about high BP and the overall effect on health”; “Self-monitoring already part of the patients’ routine/lifestyle”; and “Inspired by the study”. For patients who did not want to continue/start self-monitoring, comments fell into five overarching themes: “Anxiety or concerns about self-monitoring”; “BP measured at the surgery”; “Feels BP is controlled”; “Not interested in self-monitoring”; “Never considered self-monitoring or had the opportunity to do it”. Self-management provides additional features over-and-above self-monitoring including: a medication plan in advance, training patients to understand and interpret BP targets, when to increase medication and links with a health professional. These features appear to keep patients motivated to use self-monitoring as a way of managing their BP long-term and should be considered when starting patients to self-monitor.

About this research paper

What this paper is about

Objective: Self-management in the TASMIN-SR trial successfully reduced and controlled blood pressure (BP) compared to clinic monitoring over 12 months. This study aimed to assess how self-management affected patient preference towards future management of BP. Design and Methods: Patients with hypertension, above target clinic BP and one-or-more of stroke, diabetes, coronary heart disease or chronic kidney disease, were randomised to a self-management intervention (self-monitoring with self-titration) or usual clinic BP management. At baseline and 12 months patients were asked to rank methods of BP measurement and at 12 month follow-up were asked: “Are you planning to continue/start to self-monitor your BP after the study? Why?” Responses were coded thematically by trial arm and according to whether patients planned to continue self-monitoring. Themes were identified from the resulting codes. Scientific Data: Quantitative data regarding ranked preference for self-monitoring plus qualitative data from free text responses. Results and Conclusions: At baseline, self-monitoring was ranked as the preferred method of BP measurement by both intervention and usual care groups, but only intervention patients continued to rank self-monitoring as their preferred choice at 12 months, usual care patients preferring health professional measurement. Self-management patients were three times more likely to want to continue self-monitoring following the trial (OR 3.9 (95% CI 2.62 – 5.87; p < 0.0001). Overarching themes summarising reasons expressed by patients who wanted to continue self-monitoring included: “Positive effects of self-monitoring”; “Concern about high BP and the overall effect on health”; “Self-monitoring already part of the patients’ routine/lifestyle”; and “Inspired by the study”. For patients who did not want to continue/start self-monitoring, comments fell into five overarching themes: “Anxiety or concerns about self-monitoring”; “BP measured at the surgery”; “Feels BP is controlled”; “Not interested in self-monitoring”; “Never considered self-monitoring or had the opportunity to do it”. Self-management provides additional features over-and-above self-monitoring including: a medication plan in advance, training patients to understand and interpret BP targets, when to increase medication and links with a health professional. These features appear to keep patients motivated to use self-monitoring as a way of managing their BP long-term and should be considered when starting patients to self-monitor.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: Self-management in the TASMIN-SR trial successfully reduced and controlled blood pressure (BP) compared to clinic monitoring over 12 months. This study aimed to assess how self-management affected patient preference towards future management of BP. Design and Methods: Patients with hypertension, above target clinic BP and one-or-more of stroke, diabetes, coronary heart disease or chronic kidney disease, were randomised to a self-management intervention (self-monitoring with self-titration) or usual clinic BP management. At baseline and 12 months patients were asked to rank methods of BP measurement and at 12 month follow-up were asked: “Are you planning to continue/start to self-monitor your BP after the study? Why?” Responses were coded thematically by trial arm and according to whether patients planned to continue self-monitoring. Themes were identified from the resulting codes. Scientific Data: Quantitative data regarding ranked preference for self-monitoring plus qualitative data from free text responses. Results and Conclusions: At baseline, self-monitoring was ranked as the preferred method of BP measurement by both intervention and usual care groups, but only intervention patients continued to rank self-monitoring as their preferred choice at 12 months, usual care patients preferring health professional measurement. Self-management patients were three times more likely to want to continue self-monitoring following the trial (OR 3.9 (95% CI 2.62 – 5.87; p < 0.0001). Overarching themes summarising reasons expressed by patients who wanted to continue self-monitoring included: “Positive effects of self-monitoring”; “Concern about high BP and the overall effect on health”; “Self-monitoring already part of the patients’ routine/lifestyle”; and “Inspired by the study”. For patients who did not want to continue/start self-monitoring, comments fell into five overarching themes: “Anxiety or concerns about self-monitoring”; “BP measured at the surgery”; “Feels BP is controlled”; “Not interested in self-monitoring”; “Never considered self-monitoring or had the opportunity to do it”. Self-management provides additional features over-and-above self-monitoring including: a medication plan in advance, training patients to understand and interpret BP targets, when to increase medication and links with a health professional. These features appear to keep patients motivated to use self-monitoring as a way of managing their BP long-term and should be considered when starting patients to self-monitor.

Key concepts: Medicine, Self-monitoring, Self-management, Blood pressure, Intervention (counseling), Physical therapy, Randomized controlled trial, Preference

Related papers

Back to paper searchBrowse research topicsOriginal source
SELF-MONITORING IS NOT JUST FOR A STUDY, SELF-MONITORING IS FOR LIFE — Research Paper | ScholarLens